亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

VICT2 Trait: Prognostic Alternative to Peritumoral Hepatobiliary Phase Hypointensity in HCC

医学 内科学 胃肠病学
作者
Hanyu Jiang,Hong Wei,Ting Yang,Yun Qin,Yuanan Wu,Weixia Chen,Yujun Shi,Maxime Ronot,Mustafa R. Bashir,Bin Song
出处
期刊:Radiology [Radiological Society of North America]
卷期号:307 (2) 被引量:18
标识
DOI:10.1148/radiol.221835
摘要

Background Peritumoral hepatobiliary phase (HBP) hypointensity is an established prognostic imaging feature in hepatocellular carcinoma (HCC), often associated with microvascular invasion (MVI). Similar prognostic features are needed for non-HBP MRI. Purpose To propose a non-hepatobiliary-specific MRI tool with similar prognostic value to peritumoral HBP hypointensity. Materials and Methods From December 2011 to November 2021, consecutive patients with HCC who underwent preoperative contrast-enhanced MRI were retrospectively enrolled and followed up until recurrence. All MRI scans were reviewed by two blinded radiologists with 7 and 10 years of experiences with liver MRI. A scoring system based on non-hepatobiliary-specific features that highly correlated with peritumoral HBP hypointensity was identified in a stratified sampling-derived training set of the gadoxetate disodium (EOB) group by means of multivariable logistic regression, and its values to predict MVI and recurrence-free survival (RFS) were assessed. Results There were 660 patients (551 men; median age, 53 years; IQR, 45-61 years) enrolled. Peritumoral portal venous phase hypoenhancement (odds ratio [OR] = 8.8), incomplete "capsule" (OR = 3.3), corona enhancement (OR, 2.6), and peritumoral mild-moderate T2 hyperintensity (OR, 2.2) (all P < .001) were associated with peritumoral HBP hypointensity and constituted the "VICT2 trait" (test set area under the receiver operating characteristic curve = 0.84; 95% CI: 0.78, 0.90). For the EOB group, both peritumoral HBP hypointensity (OR for MVI = 2.5, P = .02; hazard ratio for RFS = 2.5, P < .001) and the VICT2 trait (OR for MVI = 5.1, P < .001; hazard ratio for RFS = 2.3, P < .001) were associated with MVI and RFS, despite a higher specificity of the VICT2 trait for MVI (89% vs 80%, P = .01). These values of the VICT2 trait were confirmed in the extracellular contrast agent group (OR for MVI = 4.0; hazard ratio for RFS = 1.7; both P < .001). Conclusion Based on four non-hepatobiliary-specific MRI features, the VICT2 trait was comparable to peritumoral hepatobiliary phase hypointensity in predicting microvascular invasion and postoperative recurrence of hepatocellular carcinoma. © RSNA, 2023 Supplemental material is available for this article. See also the editorial by Harmath in this issue.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
科研通AI2S应助cao采纳,获得10
25秒前
31秒前
40秒前
liu发布了新的文献求助10
45秒前
jyy应助科研通管家采纳,获得10
46秒前
子爵木完成签到 ,获得积分10
50秒前
科研小刘发布了新的文献求助10
1分钟前
1分钟前
chi完成签到 ,获得积分10
1分钟前
大个应助科研小刘采纳,获得10
1分钟前
迷你的靖雁完成签到,获得积分10
1分钟前
乐乐完成签到,获得积分10
2分钟前
2分钟前
淡然平蓝发布了新的文献求助10
2分钟前
2分钟前
2分钟前
天才小熊猫完成签到,获得积分10
2分钟前
jiangchuansm发布了新的文献求助20
2分钟前
2分钟前
科研小刘发布了新的文献求助10
2分钟前
linuo完成签到,获得积分10
2分钟前
orixero应助Aira采纳,获得10
2分钟前
3分钟前
xiekunwhy完成签到,获得积分10
3分钟前
夜阑听雨完成签到,获得积分0
3分钟前
容若发布了新的文献求助10
3分钟前
远方发布了新的文献求助10
3分钟前
4分钟前
科研小刘发布了新的文献求助10
4分钟前
lingduyu发布了新的文献求助10
4分钟前
4分钟前
4分钟前
激动的似狮完成签到,获得积分10
4分钟前
4分钟前
4分钟前
Ying完成签到,获得积分10
4分钟前
lingduyu完成签到,获得积分10
5分钟前
健忘沛春完成签到 ,获得积分10
6分钟前
Singularity应助Milesma采纳,获得10
6分钟前
6分钟前
高分求助中
The Young builders of New china : the visit of the delegation of the WFDY to the Chinese People's Republic 1000
юрские динозавры восточного забайкалья 800
English Wealden Fossils 700
Chen Hansheng: China’s Last Romantic Revolutionary 500
宽禁带半导体紫外光电探测器 388
Case Research: The Case Writing Process 300
Global Geological Record of Lake Basins 300
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3142675
求助须知:如何正确求助?哪些是违规求助? 2793563
关于积分的说明 7806945
捐赠科研通 2449831
什么是DOI,文献DOI怎么找? 1303518
科研通“疑难数据库(出版商)”最低求助积分说明 626959
版权声明 601314